Literature DB >> 24494012

Eligibility requirements for community pharmacy medication review services in Canada.

Robert Pammett1, Derek Jorgenson1.   

Abstract

Year:  2014        PMID: 24494012      PMCID: PMC3908618          DOI: 10.1177/1715163513514006

Source DB:  PubMed          Journal:  Can Pharm J (Ott)        ISSN: 1715-1635


× No keyword cloud information.
  4 in total

1.  Adverse drug events in high risk older outpatients.

Authors:  J T Hanlon; K E Schmader; M J Koronkowski; M Weinberger; P B Landsman; G P Samsa; I K Lewis
Journal:  J Am Geriatr Soc       Date:  1997-08       Impact factor: 5.562

Review 2.  A systematic review and meta-analysis of pharmacist-led fee-for-services medication review.

Authors:  Ernieda Hatah; Rhiannon Braund; June Tordoff; Stephen B Duffull
Journal:  Br J Clin Pharmacol       Date:  2014-01       Impact factor: 4.335

3.  Indicators for the selection of ambulatory patients who warrant pharmacist monitoring.

Authors:  J A Koecheler; P W Abramowitz; S E Swim; C E Daniels
Journal:  Am J Hosp Pharm       Date:  1989-04

4.  Risk factors for adverse drug events among older adults in the ambulatory setting.

Authors:  Terry S Field; Jerry H Gurwitz; Leslie R Harrold; Jeffrey Rothschild; Kristin R DeBellis; Andrew C Seger; Jill C Auger; Leslie A Garber; Cynthia Cadoret; Leslie S Fish; Lawrence D Garber; Michael Kelleher; David W Bates
Journal:  J Am Geriatr Soc       Date:  2004-08       Impact factor: 5.562

  4 in total
  16 in total

1.  Rationale and model for integrating the pharmacist into the outpatient referral-consultation process.

Authors:  Erin Keely; Corey Tsang; Clare Liddy; Barbara Farrell; Barry Power; Cynthia Way
Journal:  Can Fam Physician       Date:  2016-02       Impact factor: 3.275

2.  Inconsistencies in eligibility criteria for medication assessment programs.

Authors:  Kendra Townsend
Journal:  Can Pharm J (Ott)       Date:  2014-05

3.  A comparison of drug therapy problems in patients eligible and ineligible for provincial medication review programs in Canada.

Authors:  Robert Pammett; Derek Jorgenson
Journal:  Can Pharm J (Ott)       Date:  2016-03-29

4.  Exploring the practical application of the concept of frailty in pharmacy practice.

Authors:  Lori Blain; Priti Flanagan
Journal:  Can Pharm J (Ott)       Date:  2017-11-20

5.  Uptake of the Medication Assessment Program in Saskatchewan: Tracking claims during the first year.

Authors:  Lynette Kosar; Nianping Hu; Lisa M Lix; Yvonne Shevchuk; Gary F Teare; Anne Champagne; David F Blackburn
Journal:  Can Pharm J (Ott)       Date:  2017-11-29

6.  Uptake of the MedsCheck annual medication review service in Ontario community pharmacies between 2007 and 2013.

Authors:  Lisa Dolovich; Giulia Consiglio; Linda MacKeigan; Lusine Abrahamyan; Petros Pechlivanoglou; Valeria E Rac; Nedzad Pojskic; Elizabeth A Bojarski; Jiandong Su; Murray Krahn; Suzanne M Cadarette
Journal:  Can Pharm J (Ott)       Date:  2016-08-09

7.  Impact of pharmacist-led medication assessments on opioid utilization.

Authors:  Hishaam Bhimji; Eric Landry; Derek Jorgenson
Journal:  Can Pharm J (Ott)       Date:  2020-03-13

8.  The Ontario Pharmacy Evidence Network Atlas of MedsCheck services.

Authors:  Qihang Gan; Avery S Loi; Maha Chaudhry; Nancy He; Ahmad Shakeri; Lisa Dolovich; Suzanne M Cadarette
Journal:  Can Pharm J (Ott)       Date:  2022-03-09

9.  Community pharmacists' experiences with the Saskatchewan Medication Assessment Program.

Authors:  Krysta Currie; Charity Evans; Kerry Mansell; Jason Perepelkin; Derek Jorgenson
Journal:  Can Pharm J (Ott)       Date:  2019-02-27

10.  Provincial Comparison of Pharmacist Prescribing in Canada Using Alberta's Model as the Reference Point.

Authors:  Surya Bhatia; Scot H Simpson; Tammy Bungard
Journal:  Can J Hosp Pharm       Date:  2017-10-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.